141 related articles for article (PubMed ID: 7528361)
1. Antiproteases and dialysis arthropathy.
Docci D; Baldrati L; Capponcini C; Neri L; Feletti C
Nephrol Dial Transplant; 1994; 9(8):1204-6. PubMed ID: 7528361
[No Abstract] [Full Text] [Related]
2. Serum alpha-1-antitrypsin in hemodialysis patients with dialysis arthropathy.
Docci D; Bilancioni R; Baldrati L; Capponcini C; Delvecchio C; Feletti C
Int J Artif Organs; 1993 Mar; 16(3):123-7. PubMed ID: 8314633
[TBL] [Abstract][Full Text] [Related]
3. [Amyloidosis associated with dialysis].
Fernández E; Torras J
Med Clin (Barc); 1990 Mar; 94(12):451-3. PubMed ID: 2195253
[No Abstract] [Full Text] [Related]
4. Aluminium and dialysis associated arthropathy.
Netter P; Kessler M; Gaucher A; Burnel D; Fener P
Nephron; 1991; 59(4):669. PubMed ID: 1766513
[No Abstract] [Full Text] [Related]
5. [Pathogenesis of amyloidosis: a role for anti-proteases?].
Argilés i Ciscart A; Mourad G
Nephrologie; 1991; 12(2):51-4. PubMed ID: 1719439
[TBL] [Abstract][Full Text] [Related]
6. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
McCarthy JT; Williams AW; Johnson WJ
J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
[TBL] [Abstract][Full Text] [Related]
7. Beta-2-microglobulin amyloidosis and osteo-articular pathology of the uremic patient on regular dialysis.
Brancaccio D; Anelli A; Gallieni M; Padovese P; Coggi G; Uslenghi C
Contrib Nephrol; 1990; 77():177-86. PubMed ID: 2188786
[No Abstract] [Full Text] [Related]
8. Dialysis-related amyloidosis.
Manske CL
J Lab Clin Med; 1994 Apr; 123(4):458-60. PubMed ID: 8144992
[No Abstract] [Full Text] [Related]
9. Beta 2-microglobulin-related amyloidosis: where do we stand?
Gejyo F; Arakawa M
Nephrol Dial Transplant; 1995; 10(2):155-7. PubMed ID: 7753446
[No Abstract] [Full Text] [Related]
10. New aspects in the pathogenesis of dialysis-related amyloidosis: role of beta 2-microglobulin modified with advanced glycation end products in bone and joint destruction.
Miyata T; Maeda K
Nephrol Dial Transplant; 1996; 11 Suppl 2():140-3. PubMed ID: 8804015
[No Abstract] [Full Text] [Related]
11. Beta-2-microglobulin amyloidosis in long-term dialysis patients.
Stone WJ; Hakim RM
Am J Nephrol; 1989; 9(3):177-83. PubMed ID: 2667360
[No Abstract] [Full Text] [Related]
12. Prevalence of HLA-B27 antigens in patients with dialysis-related beta 2-M amyloidosis.
Charmes JP; Drouet M; Leroux-Robert C; Ton That H; Bouteiller G
Clin Nephrol; 1991 Oct; 36(4):214. PubMed ID: 1959251
[No Abstract] [Full Text] [Related]
13. Amyloidosis in chronic hemodialysis: rheumatological aspects.
Bouteiller G; Ton That H; Goudable C; Goffinet F; Heche JP; Orfila C; Suc JM
Contrib Nephrol; 1988; 62():67-74. PubMed ID: 3282800
[No Abstract] [Full Text] [Related]
14. Dialysis amyloidosis.
Lancet; 1991 Aug; 338(8763):349-50. PubMed ID: 1677703
[No Abstract] [Full Text] [Related]
15. Dialysis amyloidosis.
van Ypersele de Strihou C; Honhon B; Vandenbroucke JM; Huaux JP; Noël H; Maldague B
Adv Nephrol Necker Hosp; 1988; 17():401-21. PubMed ID: 3124550
[No Abstract] [Full Text] [Related]
16. [Amyloid arthropathy in hemodialysis patients].
Muñoz Gómez J
Med Clin (Barc); 1987 Feb; 88(5):192-4. PubMed ID: 3550308
[No Abstract] [Full Text] [Related]
17. CAPD, protective against developing dialysis-associated amyloid?
Sethi D; Brown EA; Gower PE
Nephron; 1988; 50(1):85-6. PubMed ID: 3050576
[No Abstract] [Full Text] [Related]
18. Alpha 2-macroglobulin protects some of the protein constituents of dialysis-associated amyloidosis from protease degradation.
Gouin-Charnet A; Mourad G; Argilés A
Biochem Biophys Res Commun; 1997 Feb; 231(1):48-51. PubMed ID: 9070217
[TBL] [Abstract][Full Text] [Related]
19. [Beta-2 microglobulin and amyloid osteoarthropathy in patients undergoing chronic hemodialysis].
Prinseau J; Baglin A; Benoit J; Leparc JM; Got C; Louis MF; Attar B; Fritel D
Ann Med Interne (Paris); 1989; 140(2):94-8. PubMed ID: 2662855
[TBL] [Abstract][Full Text] [Related]
20. Dialysis-related beta 2 microglobulin-amyloid arthropathy. Improvement of clinical symptoms after a switch of dialysis membranes.
Hardouin P; Flipo RM; Foissac-Gegoux P; Dumont A; Duquesnoy B; Delcambre B
Clin Rheumatol; 1988 Mar; 7(1):41-5. PubMed ID: 3044672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
